Evidence map›Paper›PMID 22054531›Full record

Trial reportEvaluation and program planning2012

A community prevention model to prevent children from inhaling and ingesting harmful legal products.

K W Johnson, J W Grube, K A Ogilvie, D Collins, M Courser, L G Dirks, D Ogilvie, D Driscoll

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Evaluation and program planning, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Primary healthcare approach to substance abuse management.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2021
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

K W JohnsonPacific Institute for Research & Evaluation - Louisville Center, Louisville, KY 40208, USA. kwjohnson@pire.org
J W Grube
K A Ogilvie
D Collins
M Courser
L G Dirks
D Ogilvie
D Driscoll

Funding

A Community Trial To Prevent Inhalant Use In AlaskaR01DA015966 · NIDA · PACIFIC INSTITUTE FOR RES AND EVALUATION · PI GRUBE, JOEL WILLIAM · 2004 to 2013
$6.2M
NIDA NIH HHS R01 DA015966NIDA NIH HHS R01DA015966-05
6 · The paper itself

Abstract

Children's misuse of harmful legal products (HLPs), including inhaling or ingesting everyday household products, prescription drugs, and over-the-counter drugs, constitutes a serious health problem for American society. This article presents a community prevention model (CPM) focusing on this problem among pre and early adolescents. The model, consisting of a community mobilization strategy and environmental strategies targeting homes, schools, and retail outlets, is designed to increase community readiness and reduce the availability of HLPs, which is hypothesized to reduce HLPs use among children. The CPM is being tested in Alaskan rural communities as part of an inprogress eight-year National Institute on Drug Abuse randomized-controlled trial. This paper presents the CPM conceptual framework, describes the model, and highlights community participation, challenges, and lessons learned from implementation of the model over a 21-month period.

Indexed as

Harm ReductionAdministration, InhalationAdolescentAlaskaChildCommunity NetworksFemaleHealth PromotionHousehold ProductsHumansMaleModels, PsychologicalNonprescription DrugsPrescription DrugsPreventive Health ServicesProgram EvaluationNonprescription DrugsPrescription Drugs

Identifiers

PMID22054531
PMCPMC3210444

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.